Brief: Biosyent Reports Q4 EPS AT C$0.11
20/03/2019 12:09
March 20 (Reuters) - Biosyent Inc RX.V :
* BIOSYENT RELEASES RESULTS FOR FOURTH QUARTER AND FULL YEAR
2018
* Q4 EARNINGS PER SHARE C$0.11
* Q4 REVENUE ROSE 0.2 PERCENT TO C$5.911 MILLION
* Q4 EARNINGS PER SHARE ESTIMATE C$0.10 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX9Ld2v2
Further company coverage: RX.V
((Briefs@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid